Wellington Management Group
RXRX icon

Wellington Management Group’s Recursion Pharmaceuticals RXRX Stock Holding History

Wellington Management Group’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$465K Sell
151,419
-1,197
-0.8% -$4.63K ﹤0.01% 1781
2025
Q4 		$624K Sell
152,616
-661
-0.4% -$3.27K ﹤0.01% 1792
2025
Q3 		$748K Buy
153,277
+58,295
+61% +$306K ﹤0.01% 1830
2025
Q2 		$481K Sell
94,982
-12,494
-12% -$61.4K ﹤0.01% 1826
2025
Q1 		$569K Sell
107,476
-7,469
-6% -$54.5K ﹤0.01% 1805
2024
Q4 		$777K Buy
114,945
+9,927
+9% +$66.7K ﹤0.01% 1766
2024
Q3 		$692K Buy
+105,018
New +$753K ﹤0.01% 1771

Other funds holding RXRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return